| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,099 |
8,526 |
$640K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,551 |
11,609 |
$629K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,308 |
3,264 |
$222K |
| 99215 |
Prolong outpt/office vis |
1,555 |
1,472 |
$163K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,465 |
2,307 |
$158K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,567 |
1,552 |
$110K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
542 |
505 |
$73K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,870 |
1,789 |
$51K |
| 92551 |
|
6,602 |
6,516 |
$44K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,689 |
6,560 |
$37K |
| 99177 |
|
5,817 |
5,770 |
$30K |
| 99381 |
|
250 |
246 |
$19K |
| 36415 |
Collection of venous blood by venipuncture |
5,465 |
5,215 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,140 |
1,097 |
$13K |
| 99383 |
|
146 |
146 |
$12K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
101 |
93 |
$9K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
110 |
106 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
669 |
644 |
$7K |
| 87631 |
|
48 |
48 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
731 |
704 |
$7K |
| 99382 |
|
84 |
83 |
$6K |
| 99173 |
|
4,072 |
3,996 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
96 |
86 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
41 |
39 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
128 |
125 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
190 |
183 |
$1K |
| 96127 |
|
319 |
312 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
248 |
118 |
$797.51 |
| 36416 |
|
242 |
242 |
$687.69 |
| 99417 |
Prolong home eval add 15m |
25 |
24 |
$671.99 |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
12 |
12 |
$592.65 |
| 85018 |
|
219 |
219 |
$484.51 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
28 |
28 |
$242.60 |
| 80053 |
Comprehensive metabolic panel |
12 |
12 |
$127.98 |
| 81003 |
|
98 |
86 |
$122.50 |
| 99000 |
|
303 |
294 |
$47.77 |
| 96160 |
|
27 |
27 |
$44.16 |
| 87807 |
|
21 |
20 |
$0.00 |
| 90700 |
|
25 |
25 |
$0.00 |